WELLS FARGO & COMPANY/MN
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 72971
SAN FRANCISCO, CA
Position in MDGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,248,503
-$2,613,511 QoQ
Shares Held
26,536
-17.6% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 411 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Derivatives in MDGL
reported options exposure · as of Dec 31, 2023CallValue
$2,105,558
CallShares
9,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. MDGL ranks #17 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in MDGL
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,248,503 | 26,536 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $16,862,014 | 32,212 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $25,306,747 | 43,457 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $17,345,602 | 37,818 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $11,097,505 | 36,669 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $12,285,651 | 37,091 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $10,776,189 | 34,923 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $6,222,076 | 29,319 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $8,302,540 | 29,635 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,489,208 | 16,811 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $13,833,051 | 59,785 | Shares | Defined | 2024-02-09 | |
| 2023-12-31 | $2,105,558 | 9,100 | Call | Defined | 2024-02-09 | |
| 2023-09-30 | $2,526,492 | 17,300 | Call | Defined | 2023-11-13 | |
| 2023-09-30 | $2,937,301 | 20,113 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,508,889 | 19,519 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $3,886,092 | 16,041 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $7,409,501 | 25,528 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,686,683 | 25,953 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,305,447 | 32,208 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,394,421 | 24,403 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,381,531 | 28,104 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,287,179 | 28,665 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,016,785 | 30,970 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,971,247 | 33,951 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $4,879,361 | 43,891 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $936,066 | 7,884 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $1,104,187 | 9,750 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $536,349 | 8,034 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||